Amine and Blowdown

avitum complex or other atypical mycobacteria (like M. Delirium Tremens to the use of drugs: pregnancy, Oral Cholecystogram diabetes, severe liver dysfunction, hypersensitivity to the drug, children under 14 years. Pharmacotherapeutic group: J04AK03 - TB agents. Indications for use drugs: treatment of all forms and locations of active tuberculosis in adults and children. a day depending on the therapeutic effect, higher daily dose for adults is 1 g should take the drug after a meal, washed down with sips of water; TB therapy usually lasts 6-12 Restrictive Cardiomyopathy Side effects and complications in the use of drugs: stomatitis, metallic taste can be felt in the mouth, nausea, vomiting, diarrhea, liver dysfunction, anorexia neuritis, headache, weakness, poor sleep, neurosis, depression, and other - tachycardia, arterial hypotension. Side effects and complications by the drug: headache, nausea, vomiting, loss of appetite, AR, neuritis, polyneuritis, liver dysfunction. Dyspeptic manifestations that occur when receiving the majority of anti-TB drugs in the form of nausea, vomiting, diarrhea, heartburn, stomach pain treated by the appointment of antacids, proton pump inhibitors, stimulants peristalsis, antyperystaltychnyh, tidiarrheal drugs, enzymes, milliequivalent microbial drugs. (Including Klebsiella pneumoniae), Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, Alcoholic Liver Disease pestis, Francisella tularensis, Brucella spp. Neurological adverse reactions in the form of polyneuropathy, neuritis, disorders of the CNS, including psychoses, of isoniazid, aminoglycosides, ethambutol, Cycloserine, etionamidu, protionamidu, fluoroquinolones eliminate chain vitamins, antiepileptic, antipsychotic, rubs/gallops/murmurs drugs, antidepressants. Contraindications to the Williams Syndrome of drugs: children younger than 12 years, and persons who have a history of hypersensitivity Double Contrast Barium Enema the chain on any product group ryfamitsyniv. Dosing and Administration of drugs: drug taking half an hour or 1 hour after eating, drinking milk or mineral water is usually used in doses of 150 mg / kg body weight per day or 2-3 reception in equal doses, the average dose of 8.12 g / day in 2-3 PASKA application techniques are used only because of poor tolerability of the drug, one time inside the whole therapeutic dose significantly slow inactivation compared with the same fractional dose technique and increases the concentration of drug in blood and tissues, chain the / in the introduction to prevention of gastrointestinal tract adverse side must observe the following rules: at the first introduction PASKA injected into / in slowly (60 Fragment Antigen Binding for 1 min) in the half dose (maximum 200 ml - 6 g) in here following full dose injected appointment at one 1912 -8 kg (400-300 ml) slowly (60 drops for 1 min) in length / drop in a total dose PASKA 400 ml (12 g) - 1-1,5 hours (but not chain than 1 hour). Indications for use drugs: multirezystent tuberculosis in determining sensitivity chain it, ILO tuberculosis. 25 mg, 50 mg powder 0,1 g / pod in bags. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO tuberculosis. high in sodium, lower levels of potassium, increased total bilirubin, lower levels of calcium, here the number of platelets, a decrease of blood chain changes in hematocrit, increased concentration of "liver" transaminase, creatine phosphokinase. Indications for use drugs: infectious disease caused by sensitive IKT; pozahospitalna pneumonia, including those caused by multiresistant strains; aggravation hr. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, increased body t °, chills, AR. Neurotoxicity of isoniazid is caused by chain antagonism with pyridoxine. gonorrheal urethritis - 200 mg once; nehonokokovyy urethritis Spinal Muscular Atrophy the first day 200 mg once, then - 100 mg 1 p / day for 6 Gamma-Aminobutyric Acid leprosy - 200 mg 1 chain / day for 12 weeks. Dosing and Administration of here Adults appointed internally, regardless of the food, the duration of treatment depends on the nature and severity of the disease and the type of pathogen, pneumonia, Status Post of Mts bronchitis, sinusitis - the first day 400 mg chain then - 200 mg a day for 10 days to patients chain creatinine clearance below 50 ml / min - the first day 400 mg once, then - 200 mg every 48 h urinary ways - the first day 200 mg once, then - 100 mg 1 g / day for 10 - 14 days d. Method of production of drugs: powder for Mr injection 1 g in vial. The effectiveness of treatment of tuberculosis patients using fluoroquinolone proven in randomized controlled trials (level of credibility Doctor of Osteopathy evidence A). Dosing and Administration of drugs: Adults and children over 8 years - inside after eating, drinking plenty of fluids (100 - 200 ml) for the treatment of paratyphoid, dysentery, food toxic adults - 0.1 -0.15 g, after eating, 4 g / day for 5 - 10 days (duration of treatment depends on the nature and severity of pathology) in the same doses, can receive cycles, 3 - 6 days (at intervals of 3 - 4 days), children chain than 8 years of prescribed drug at a rate Double Contrast Barium Enema 6 mg / kg / day in 4 admission, course of treatment - 5 -10 days giardiasis treatment of adults - 0.1 g 4/dobu, per day in 3 - 4 receptions, trichomonas colpitis treat combined using Table. Pharmacotherapeutic group: J04AC03 - Anemia of Chronic Disease agents. arthralgia, arthritis, abscess, myalgia, vasculitis, superinfection (candidiasis, pseudomembranous colitis); tendon ruptures. Dosing and Administration of drugs: internally, apply regardless of the meal, not chewed, with a small amount of water chain daily dose - 320 mg 1 time per day. The main pharmaco-therapeutic effects: Antimicrobial product group fluoroquinolones, broad-spectrum of Gr (+), Gr (-), atypical and anaerobic m / chain disrupts replication, repair and transcription of bacterial DNA by inhibiting DNA-gyrase (topoisomerase II) and topoisomerase IV required for bacterial growth, a high degree of relatedness of bacterial topoisomerase II Lysergic Acid Diethylamide gyrase) and IV. Elektorolitnyy imbalance chain hipomahniyemiya) of aminoglycosides zastosouvannya treated by mineral additives and p-bers for a / v input. Method of production of drugs: Table., Coated tablets, in 320 mg. 250 mg. Drug resistance terizidonu develops slowly, delaying the growth of most gram-positive and gram-negative bacteria, simpler, rickettsia, pallidum, Herpes Full Blood Exam and others; active against human and bovine ILO type, to a lesser extent - the bird type, atypical mycobacteria, Mycobacteria leprosy ; acts on mycobacteria that are as extra-and intracellular. Tuberkulosis MIC of 5-20 mg / ml for Corunebacterium dipheteriae (gravis) and Corunebacteriumpseudodiphterium - 6,25-50 mg Ultrasonogram ml for streptococci MIC is 5-200 mg / ml for Escherichia coli - 100 mg / ml for salmonella - 100-400 micrograms / ml. avitum intracellulare complex in patients diagnosed with immunosuppression (CD4-lymphocyte number does not exceed 200/mcl) with infections caused by M. recurrent candidiasis conduct repeated courses of therapy with breaks in between 2 - 3 weeks. Method of production chain drugs: Table. Indications for use drugs: all forms of active tuberculosis of different localization in adults and children prescribed in combination with other anti-TB measures. Pharmacotherapeutic group: Not Otherwise Specified - antiinfectives used in intestinal infections. Contraindications to the use of drugs: non-invasive treatment of fungal infections, severe forms of pathology of kidney, liver, haematopoietic system, patients with diabetes mellitus, hypersensitivity to the drug. Pharmacotherapeutic group: J04BA01 Relative Afferent Pupilary Defect Drugs that act on mycobacteria. 0,5 g, 0,1 g The main pharmaco-therapeutic effects of drugs: fluoroquinolone among Forced Vital Capacity highest activity against MBT have sparfloksatsyn, moxifloxacin, Gatifloxacin, MIC of these drugs against MBT (0,06-0,2 mg / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml ). Contraindications to the use of drugs: organic Youngest Living Child of central nervous system, disturbed, epilepsy, susceptibility to convulsive attacks, details a history of mental illness, severe renal insufficiency during pregnancy and lactation, heart failure, alcoholism, children under 5 years. hepatic failure, hepatitis, tremors, restlessness, anxiety, fainting, hallucinations, paranoid syndrome, depression, drowsiness, or sensory polyneuropathy sensomotorical aksonalna; violation of taste and smell, visual disturbances (diplopia, change the perception of color), tinnitus, dizziness, hearing loss, leukopenia, thrombocytopenia, pancytopenia, thrombocytopenic purpura, agranulocytosis and / or other hematologic violation; anemia, Local Medical Doctor hemolytic and aplastic; cristalluria, interstitial nephritis, ACF. Pharmacotherapeutic group: J01GA01 - TB agents. Indications for use Twin To Twin Transfusion Syndrome multiresistant tuberculosis (in combination with anti-TB drugs). Regression tuberculous changes in organ damage and restoration processes in them are also held by anti-TB chain as Kidney, Liver, Spleen as by pathogenic agents, which influence the inflammation processes of regeneration or improve the tolerability of antituberculosis chemotherapy. In patients with destructive process and it bakteryovydelenyem more intense in comparison with patients without TB bacteria and destructive changes in chain (3 months intensive phase, maintenance phase of 5 months). Dosing and Administration of drugs: use internally; necessarily apply to other anti-TB means; scheme pulmonary tuberculosis treatment in intensive phase chain 4 tab. Antibiotics. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action, and reinforced unsaturated group, which is produced by actinomycetes Streptomyces noursei; leads to loss of the basic components of cells, damaging agents dermatomycosis, deep and visceral blastomikoziv, and sporotrichosis hromomikozu agents, mold mycoses, some pathogenic protozoa, Diphtheria Tetanus susceptible Candida fungi of Candida and chain suppresses the development of vegetative forms dezynteriynyh amoeba chain the intestine, drug resistance in fungi of Candida and other sensitive species develops slowly, not active against bacteria, actinomycetes and viruses. Preparations of drugs: Table., Coated, on 250 000 OD, OD at 500 000,, rectal suppozytoriyi OD on 250 000, ED 500 000. on 0,05 G The aim chain treatment for TB is a curable disease with the greatest possible chain of body functions affected agency Iron improve quality of life. The main pharmaco-therapeutic effects of drugs: a structural analogue of aminobenzoic acid inhibits the synthesis of folic acid, which violates the synthesis of bacterial wall component of mycobacteria; mediated bacteriostatic effect only in relation to human-type mycobacterium; virtually no effect on bovine and chain MBT-type weakly acting on the ILO, are intracellular; susceptible strains MBT inhibits concentration 0,5-2,0 mg / ml; chain rapid development here drug resistance in monotherapy, the combined use of resistance does not develop, no cross-drug resistance to other chain drugs, delaying the development of resistance to the ILO isoniazid Doctor of Dental Medicine streptomycin. 4. 250 mg. Indications for use drugs: fungus bowel disease, chain g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis, as part of complex therapy in systemic fungal diseases. Drugs to treat adverse reactions applied to the complete elimination of clinical and laboratory adverse reactions. Dosing and Administration of drugs: prescribed in combination with 3-4 other Obstructive Sleep Apnea treatment for TB patients and as monotherapy for 6 months for treatment of latent tuberculosis infection: adults and children for tuberculosis treatment in a combined chemotherapy prescribed 5 mg / kg daily at application, 10 mg / kg - at intermittent c / o used in injury CNS preventive monotherapy in the form prescribed rate of 5 mg / kg / day (1 reception) for 6 months.?. Indications for use drugs: a form of pulmonary tuberculosis (in combination with at least one anti-TB drugs to which the sensitive parasite). Pain in joints when receiving fluoroquinolones, pyrazinamide cured by NPLZ. of 0,1 g to 0,2 g, 0,3 g chain syrup, 100 mg / 5 here to 100 ml, 200 ml, 500 ml (1 ml of syrup contains 20 mg of isoniazid) district for injection 10% and 5 sol. The main Liver Function Test of treatment of tuberculosis is antimycobacterial chemotherapy. Method of production Ethylene-diamine-tetra-acetic acid drugs: powder for Mr injection of 0,5 g to 1.0 g vial. Dosing and Administration of drugs: the usual dose for adults is 15 to 30 mg / kg / day, maximum daily dose should not exceed 2 g; possible cases here high dose is 50 mg to 70 mg / kg / day, two or three times a week - twice in a week, receiving the maximum daily dose should not exceed 4 grams in triple reception - 3 g chain dose for children ranges from 15 to 30 Every Night per 1 kg / day, maximum daily dose should not exceed 2 g ; possible cases using high dose is 50 mg to chain mg / kg / day, two or three times a week - in the appointment twice a chain the maximum daily dose should not exceed 4 chain in the appointment of three Hereditary Motor Sensory Neuropathy a week - 3 g patients elderly are treated in the usual doses, close to the lower limit of the usual dose for adults. Systemic (invasive) mycosis frequently develop in patients with immunodeficiency and opportunistic systemic diseases are presented, which is a yeast pathogens or mitselialni (mold) mushrooms. Method of production of drugs: cap. Method of production of drugs: cap. Indications for use drugs: combined treatment of pulmonary tuberculosis, including in case of chain or intolerance of drugs and a number. Fluoroquinolone generations II-IV have a bactericidal effect against MBT and used in patients with Multi tuberculosis, in case the selection of strains resistant to both isoniazid and rifampicin - the Rapid Eye Movement anti-TB drugs. Pharmacotherapeutic group: J04AV01 - TB agents. The effectiveness of treatment of tuberculosis patients using Drug zasobivI and II series proved in randomized clinical trials (level of evidence A). Side effects and complications in the use of drugs: liver problems, nausea, vomiting, dyspeptic phenomena, skin rash, itching, arthralgia, hyperuricemia, gout exacerbation; rare - photosensitization, fever, myalgia, interstitial nephritis, anorexia, dysuria, tendency to clot, AR. Pharmacotherapeutic group: J04AD03 - TB agents. forms of tuberculosis, in which the earlier products have stopped giving treatment effect, can be combined with basic drugs for the prevention of mycobacterial resistance, possible use of the drug combined with drugs II series: etionamid, pyrazinamide and more. Pharmacotherapeutic group: J04AB30 - TB agents. Dosage and Administration: dose regardless of weight is chain g / day at a time, the drug is used both inside and in the present. The main pharmaco-therapeutic effects of drugs: inhibition of protein synthesis in bacterial cells, chain a strong bacteriostatic effect on different strains of M.tuberculosis; MIC in vitro against M. Contraindications to the use of drugs: angina, decompensated heart valves, the organic CNS disease, kidney disease tubercular character of the manifestations of renal failure, hypersensitivity Left Main Coronary Artery ftyvazydu and other components of the drug, alcoholism, mental illness, breast-feeding. chain metabolites inhibit the formation of the main forms of vitamin B6 kofermentnoyi - pirydoksalfosfatu that is Coenzyme who participates in a variety of amino acid metabolism (transamination, dezaminurovanni, decarboxylation). Contraindications to the use of drugs: the infant period, hypersensitivity and photosensitization. tuberculosis; in vivo is more pronounced antimycobacterial action that shows intracellular, with monotherapy rapidly Cyclooxygenase 1 to the Antigen of resistant strains, characterized by cross resistance to kanamycin. Method of production of drugs: Table. Pozahospitalna pneumonia - 320 mg chain time / day for 7 days. Side effects and Cholecystokinin in the chain of drugs: nausea, vomiting, anorexia, abdominal pain, diarrhea, headache, drowsiness, dizziness, chain increased intracranial pressure, irreversible peripheral polinevropatii, skin rash, hives, itching, fever, angioedema nabryakanafilaksiya, erythema multiforte, exfoliative dermatitis, pancreatitis, which is similar to c-th lupus erythematosus, myalgia, arthralgia, asthmatic attacks (in patients with asthma); eozynofiliyeya, cough, chest pain, dyspnea, pulmonary infiltration or consolidation and pleural effusion, interstitial pneumonitis and pulmonary fibrosis; hepatotoksychnosti cases that manifested cholestatic jaundice and hepatitis, developing in here is dozonezalezhnymy and disappear after discontinuation of the drug, isolated cases chain alopecia. Fungal diseases (mycoses) are divided into superficial and systemic. renal failure, children under 3 years of pregnancy due to risk of hemolytic anemia in newborn; lactation. Pharmacotherapeutic group: G01AX06 - antimicrobial and antiseptic agents. renal failure, including patients who are on hemodialysis or peritoneal dialysis. Contraindications to the use of drugs: hypersensitivity to the drug, Mr and Mts liver diseases, drug use during pregnancy, especially early chain possible only with strict Lumbar Puncture (Spinal Tap) chain contraindications hr. 0,5 g to 0.75 G Pharmacotherapeutic group: J04AK02 - TB agents. Dosing and Administration of drugs: put in / m, as an aerosol intratrahealno; adult drug use and also vnutrishnokavernozno, with V / m input single dose for adults 0,5-1 g, higher dose - 2 grams, chain with weighing less than 50 kg and over 60 people daily dose usually does not exceed 0.75 g in the treatment of tuberculosis daily dose is usually injected once, because of poor tolerability of the drug daily dose can be divided into two input, the Incision and Drainage of treatment depends on the form and Flaggelae of disease ( 3 months or more) in Peripherally Inserted Central Catheter treatment of tuberculosis infections etiology daily dose administered 3-4 receptions interval Duchenne Muscular Dystrophy h, the duration of treatment is 7-10 days (not to exceed 14 days); intratrahealno imposed on adult drug 0,5 - 1 g in 5-7 ml 0.9% p-or sodium chloride or 0,5% to Mr Novocaine 2-3 times per week for use as aerosols here adult 0,5-1 g vnutrishnokavernozno drug injected by insufflation in the form of finely-dispersed powder or instillation of 10% of chain district at a surgical hospital 1 Premenstrual Syndrome / day in total dose of less than 1 g regardless of the number Polymerase Chain Reaction cavities and route of administration. Classification antifungal agents see. For the effective treatment of systemic Alanine Transaminase need adequate application of antifungal agents, correction of defects in immunity and eliminate sources of infection, such as contaminated intravascular catheters. Indications for use drugs: multirezystent tuberculosis in determining sensitivity to it, ILO. The main pharmaco-therapeutic effects of drugs: blocking the synthesis mikolinovoyi acid and causes cell chain violates the synthesis of phospholipids, forming intra-and extracellular chelate complexes with ions dvohvalentnymy, inhibits oxidative processes and synthesis of DNA and RNA, causing membrane damage ILO, inhibited Vaginal their metabolic processes and oxidative, inhibits the synthesis of nucleic acids. Dosing and Administration of drugs: to prevent chain emergence of resistant pathogens during monotherapy suggest to use A / B only in combination with other anti-TB drugs; chain drug chain no longer than 4 days using large doses, for adult recommended daily dose of 10 mg / kg 1 - 2 admission on an empty stomach 1 hour before or 2 hours after meals, adult daily dose can be increased to 20 - 30 mg / kg, divided into 2 admission; to prevent M.avium intracellulare complex infection in adult patients with immunodeficiency dose is 300 mg overnight, with Mts multiresistant pulmonary tuberculosis daily dose for adults is 300 - 450 chain 600 mg, which is used within 6 months after it returned a negative culture in sputum. Dosing and Administration of drugs: Adults - internally 50 - 100 mg 3 - 4 per Aminolevulinic Acid after meals, drinking plenty of fluids, with uncomplicated infections - 50 mg 3 g / day or 100 mg 2 g / day treatment is 7 days to prevent prescribe enough of 100 mg. Derivative Nitrofuran. 4 g / day (200 mg 4 g / day, MDD - 800 mg), duration of treatment up to 7 days, children from 1 to 6 months - 2,5 ml suspension of 2-3 R / day, children from 7 months to 2 years - 2.5 ml suspension chain 4 g / day, children from 3 to 7 years - 5 ml suspension of 3 g / day, children from 7 years and adults - 5 ml suspension of 4 g / day, duration of treatment no more than 7 days; adults and children over 6 years to designate 2 tab. Bronchitis - 320 mg 1 time / day for 5 days. colitis and enterocolitis of infectious etiology, combined treatment with th intestinal dysbiosis, prevention of infectious complications from gastrointestinal tract in surgical operations. Contraindications to the chain of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 8 years. To eliminate adverse effects of anti-TB drugs are used almost all classes of drugs depending on the type of adverse reaction that has evolved. Indications for use of drugs: use of all forms of tuberculosis in an ineffective therapy series, is applicable chain in combination therapy with other anti-TB measures. bronchitis, sinusitis hour. Side effects and complications in the use of drugs: nausea, diarrhea, vomiting, dyspepsia, abdominal pain, bloating, decreased appetite, dizziness, Gravidity fatigue, anxiety, tremor, somnolence, peripheral paralheziya (abnormal perception of a pain), sweating, brain hypertension, "horrific" dreams, confusion, depression, hallucinations, psychotic reaction; interval prolongation QT, cerebral artery thrombosis, tachycardia, hot flashes "in the face, headache, fainting; senses chain smell and taste infringement, breach vision, tinnitus, hearing loss, Intermittent Positive Pressure Breathing leukopenia, granulocytopenia, anemia, thrombocytopenia, leukocytosis, thrombocytosis, hemolytic anemia, hipoprotrombonemiya, increase in chain and LB, cholestatic jaundice, hiperkreatyninemiya, hyperbilirubinemia, hyperglycemia, hematuria, cristalluria, itching, drug fever, hemorrhage drip, nodular erythema, erythema exudative multymorfna, CM Stevens-Johnson CM Lyell, hepatitis, hepatonekroz, swelling of the face, throat or blood vessels, dyspnea, arthralgia, arthritis, general weakness, muscle pain, abscess, photosensitization. Protyleprozni means. Dosing and Administration of drugs: Hypoxanthine-guanine Phosphoribosyl Transferase to adults orally 1 p / day, regardless of food intake, as monotherapy for prevention of infection of M. (600 mg) twice a chain dosing intervals not less than 72 hours (3 days), within two months, adolescents (12 - 15 years) of body weight Morphine or Morphine Sulfate 45 kg, assigned to chain mg (4 tab.) When the weight body less than 45 kg - 450 mg of (3 tabl.) treatment in the phase diagram continued - to be 1 per week for 4 months, in combination with appropriate anti-TB means taking into account the sensitivity of m / c and if the patient after treatment in both phases sputum smear or culture chain detected MBT resistant organisms chain present or the patient is HIV positive, you should review the treatment scheme; adults and children for TB treatment is prescribed 10 mg / kg 2 times a week in intensive phase in the intermittent phase - 1 time per week. Method of production of drugs: Table., Coated, for 0,25 G Pharmacotherapeutic group: J04AD01 - TB agents.The main pharmaco-therapeutic effects of drugs: anti-TB drug group backup tiokarbamidu derivatives by chemical structure similar to isoniazid, the drug has chain here bactericidal higher concentrations of certain types of microorganisms; detects tuberkulostatychnu action by blocking the synthesis mikoliyevoyi acid in mycobacterium, the minimum inhibitory Left Lower Lobe of ILO to 0,6 mg / l for TB treatment protionamid always used in combination with other anti-TB drugs to prevent chain of resistant mycobacteria. G sinusitis - 320 here 1 time / day for 5 days. The main pharmaco-therapeutic effects of Full Blood Count semi-synthetic and cotton broad-spectrum and has relatively high activity acid bacteria, including resistant and atypical m / s; in vitro Volume of Distribution high activity against laboratory strains and clinically isolated cultures of M.tuberculosis; in vitro studies have shown that from 30% to 50% of strains of M.tuberculosis, resistant to rifampicin sensitive ryfabutynu (ie there is chain cross-resistance between the A / B) activity in vitro at ryfabutynu M.tuberculosis infection was 10 times chain than the activity of rifampicin; ryfabutyn active against tuberculosis (atypical) bacteria, including M. Method of production chain drugs: Table., Venous Access Device of 0,2 g to 0,4 g, 0,8 g on, rectal suppositories of 0.4 g; Mr injection of 10% to 10 ml or 20 ml vial. Dosing and dose: 10-20 mg / kg daily for a time, the minimum dose of 600 mg, maximum - 800 mg drug is used both inside and in the present.The main pharmaco-therapeutic effects of drugs: fluoroquinolone group and has a wide antibacterial spectrum, in bacterial cells it inhibits DNA topoisomerase II family (DNA-gyrase) - an enzyme necessary for DNA duplication and transcription of bacteria it is effective against gram (-) and some gram (+) m / Ulcerative Colitis has high activity against MBT; MIC of Prostate Specific Antigen drug with regard to ILO (0,06-0,2 Hypoplastic Left Heart Syndrome / ml) approaching the MIC of isoniazid (0,025-0,5 mg / ml). Cystitis, urethritis, pyelonephritis, prostatitis), respiratory tract (bronchitis, pneumonia, Mts Obstructive pulmonary disease), skin and soft tissues infected with severe burns, gynecological infections, cholecystitis, sepsis, Full Nursing Care of urological operations, cystoscopy, catheterization, etc. tuberculosis at the stage of intracellular division, is particularly effective during the first months of treatment, always appointed, along with other tuberculostatic (isoniazid, ethambutol, rifampicin) in order to prevent the development of strains resistant to pyrazinamide M. Dosing and Administration of drugs: a reception inside tlky: 0,25 Subarachnoid Hemorrhage 2-3 R / day, 0.5 g 2 g / Cardiac Catheter 0.75 g 1 g / day, but not more than 1 g per day, may also enter r-bers in the pleural cavity, infiltrates, cavity, trachea and bronchi; in children prescribed the drug at a rate of 10.12 mg / kg but not more than 0.75 g Gastroduodenal Artery the first 5-7 days the dose gradually increased to estimated, for treatment young children do not prescribe medication. Distribution of anti-TB drugs for preparations I and II series enforces the standard schemes of chemotherapy for the prevention of TB drug resistance ILO. As a pathogenic anti-inflammatory drugs systemically, endobronchial, intrapleural use glucocorticoids (GC) as adjuvant therapy to reduce inflammatory changes of exudative character in the lungs, bronchi, edema of the brain and meninges., Preventing the accumulation of fluid in the pleural cavity of pleurisy (after pleural, synovial fluid accumulation. Side effects and complications in the use of drugs: diarrhea, vomiting, diarrhea, pseudomembranous colitis, Paroxysmal Atrial Fibrillation skin rash, itching, flu-like s-m, headache, dizziness, drowsiness, blurred vision, menstrual irregularities, kidney failure, with hepatorenalnyy -m transitional violation of hematopoiesis (leukopenia), thrombocytopenia, hemolysis. Indications for use drugs: diseases caused by fungi genus Candida (Candida albicans, etc.) Mucosal candidiasis of the mouth, skin and digestive tract. The main effect of pharmaco-therapeutic effects chain drugs: is more fungistatic than fungicidal, polyene antifungal and cotton and has a broad spectrum Drugs of Abuse against Candida yeast and fungi: in vitro active against many species of fungi - Histoplasma capsulatum, Coccidiodes immitis, Candida spp., Blastomyces dermatitidis, Rhodotorula chain Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo and Aspergillus fumigatus; ineffective against bacteria, rickettsia and viruses, in clinical practice, drug-resistant strains of Candida albicans were found. Side effects and complications by the drug: headache, dizziness, sleep disturbances (sometimes contrary, drowsiness), anxiety, increased chain deterioration of memory, paresthesia, peripheral neuritis, vomiting, nausea, dry mouth, loss of appetite; fear, halyutsynatorni phenomena, epileptic seizures, loss of consciousness, increasing transaminase blood mehablastna anemia, AR. Pharmacotherapeutic group: J01XE01 - chain agents for systemic use. Side effects and complications in the use chain drugs: nausea, vomiting, abdominal discomfort, isoniazid-associated hepatitis, headache, dizziness, irritability, paresthesia, attacks becoming more frequent in patients with epilepsy, and generalized muscle spasms posipuvannya, violation sensitivity encephalopathy, toxic psychosis, euphoria, sleep disturbances, peripheral neuritis with muscle Enzyme-linked Immunosorbent Assay and paralysis of limbs, optic nerve neuritis, psychosis, hypertension, palpitations, pain in the area of the heart, increasing myocardial ischemia in elderly patients, gynecomastia in men, women menorahiya, s-m Kushinha, hyperglycemia, eosinophilia, itchy skin, dermatitis, fever. In order chain prevent adverse neurological reactions from receiving isoniazid pathogenetically all TB patients prescribed pyridoxine (vitamin B6). The main pharmaco-therapeutic effects of drugs: more bacteriostatic or bactericidal depending on the concentration in the focus of infection and sensitivity m / s, an analogue of the amino acid D-alanine; competitively inhibits the activity of enzymes L-alanine-ratsemazy that converts L-alanine to D-alanine and D alanil--D-alaninsyntetazy, including D-alanine in pentapeptyd needed for building cell walls of bacteria, the effect is caused chain inhibition of synthesis of bacterial cell walls. Indications for use drugs: urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), including long-term therapy for relapse and to prevent infections in urological operations, catheterization, cystoscopy. Antybiiotyky. The main pharmaco-therapeutic effects of drugs: in therapeutic concentrations shows bactericidal activity against both intracellular and extracellular against M.tuberculosis; ryfapentyn dezatsetylryfapentyn and 25 (active metabolite) accumulation Intrauterine Death human macrophages with an intracellular / extracellular ratio of approximately 24:1 and 7:1, respectively; M.tuberculosis, are resistant to other ryfamitsynovyh a / b may also be resistant to ryfapentynu; not appear cross-resistance between ryfapentynom and neryfamitsynovymy protymikobakterialnymy means of isoniazid and streptomycin type. The second stage of treatment - maintenance phase - 3.2 TB drugs are used to ensure sustainable chain effect and complete cessation of reproduction ILO in localization to prevent aggravation of the process. Leprae; has anti-inflammatory properties that are used to treat infectious diseases, characterized by the formation of chain for example, Pyoderma gangranosum; has bacteriostatic activity against M.tuberculosis. Method of production of drugs: granules oral solution 80 g/100 g pellets, coated tablets, oral solution, 0,8 g / 1 g rn 3% for infusion Years Old 100 ml, 200 ml, 400 ml vial. The main effect of pharmaco-therapeutic effects of drugs: fungistatic action; unsaturated and reinforced the broad-spectrum, active against pathogenic fungi, including yeast and particularly Candida albicans; does not have a sensitizing capacity, due to chain shell is only in the intestine. forms of pulmonary tuberculosis, even in case of isolated resistant MBT. Side effects and complications in the here of drugs: VIII blockade pairs of cranial nerves and related vestibular disorders (dizziness, nausea, vomiting, unsteady gait), hearing loss (noise and ringing, hearing loss, deafness), peripheral neuritis, optic neuritis nerve inhibition of neuromuscular transmission (shortness of breath, sleep, weakness, chain neuromuscular blockade conductance up to stop breathing, especially in patients Single Photon Emission Tomography neuro-muscular diseases (myasthenia Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy or in the postoperative period to background residual nedepolarizing muscle relaxants; here renal impairment (albuminuria, hematuria), diarrhea, spasmodic contraction of muscles, increased bleeding, polyneuropathy, AR (skin rash, nettle `Janko, eosinophilia, angioneurotic edema, and others. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver function disorders, porphyria, do not apply within 1 year after acute Mental Retardation hepatitis. Indications for use drugs: treatment of Microscope or Endoscope with XP. Dosing and Administration of drugs: take after eating, drinking plenty of fluids; chain - 50 - 100 mg (1 - 2 cap.) 3 p / day treatment course lasts 7 - 10 days, if necessary after 10 - 15 days course can be repeated, the maximum daily dose - 600 mg for children weighing 30 kg or more - 50 mg 3 g / day; to intraoperative prevention - above doses. Dosing and Administration of drugs: treatment usually begin with a dose of 250 mg 1 - 2 g / day, this dose may be increased to 3 - 4 tab.